FDA Discussion Paper Synthesizes Stakeholder Feedback on LDT Regulation

Last December, the U.S. Food and Drug Administration announced that it would not finalize the guidance on agency oversight of laboratory developed tests (LDTs) that it proposed back in 2014— at least not yet. Instead, the FDA said it would work with the new administration and Congress "to get our approach right." With that in…